GPx combines digital biomarkers and the blood biomarkers to deliver the most actionable RPM system. We pass digital biomarkers gathered passively from wearables through our proprietary algorithms to determine the optimal time to test relevant blood biomarkers. This staged triage reduces false positives from digital biomarkers by validating via accurate and clinically acceptable, blood biomarkers, efficiently and cost-effectively. Our first product is a novel blood biomarker-assisted RPM for Heart Failure. The product is provided as a package to patients upon discharge from the hospital and includes a smartwatch, a Bluetooth wireless scale, and capillary blood collection tools. The patients wear the smartwatch while the GPx algorithm monitors trends 24/7. If a significant change is identified, the patient is notified to collect and mail a blood sample. The blood sample is analyzed and results are updated to the physician dashboard with appropriate alerts to the patient within 24 hours.
Location: United States
Investors 2
| Date | Name | Website |
| 19.04.2023 | Plug and P... | plugandpla... |
| - | MIT Alumni... | mitalumnia... |